Overview
Kevin Kemp practices in Bristol, United Kingdom. Mr. Kemp is rated as an Advanced expert by MediFind in the treatment of Hereditary Ataxia. His top areas of expertise are Friedreich Ataxia, Hereditary Ataxia, Spinocerebellar Ataxia, Multiple Sclerosis (MS), and Bone Marrow Transplant.
His clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Hereditary Ataxia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Friedreich AtaxiaMr. Kemp isDistinguished. Learn about Friedreich Ataxia.
- Advanced
- Drug Induced DyskinesiaMr. Kemp isAdvanced. Learn about Drug Induced Dyskinesia.
- Hereditary AtaxiaMr. Kemp isAdvanced. Learn about Hereditary Ataxia.
- Multiple Sclerosis (MS)Mr. Kemp isAdvanced. Learn about Multiple Sclerosis (MS).
- Spinocerebellar AtaxiaMr. Kemp isAdvanced. Learn about Spinocerebellar Ataxia.
- Experienced
- AstrocytomaMr. Kemp isExperienced. Learn about Astrocytoma.
- Bone Marrow TransplantMr. Kemp isExperienced. Learn about Bone Marrow Transplant.
- CACH SyndromeMr. Kemp isExperienced. Learn about CACH Syndrome.
- GlioblastomaMr. Kemp isExperienced. Learn about Glioblastoma.
- Relapsing Multiple Sclerosis (RMS)Mr. Kemp isExperienced. Learn about Relapsing Multiple Sclerosis (RMS).